| Bioactivity | DW71177 is a novel [1,2,4]triazolo[4,3-a] quinoxaline-based potent and BD1-Selective BET inhibitor, and can be used for study of acute myeloid leukemia[1]. |
| Name | DW71177 |
| CAS | 2241311-72-6 |
| Formula | C20H28N6O2 |
| Molar Mass | 384.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ali I, et al. DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia. Eur J Med Chem. Published online December 16, 2023. |
DW71177
CAS: 2241311-72-6 F: C20H28N6O2 W: 384.48
DW71177 is a novel triazolo quinoxaline-based potent and BD1-Selective BET inhibitor, and can be used for study of acute
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.